The present application relates to a microfluidic device, and more particularly to a microfluidic device having at least one microfluidic sensing cell located along a linear microfluidic channel, and methods of using the same.
Single cells represent a fundamental biological unit. Unfortunately, the majority of biological knowledge has been obtained by the study of larger cell populations due to either simpler, quicker, less costly instrumentation and/or sample preparation. However, there are fundamental and applied questions, such as those relating to transcriptional control of stem cell differentiation, intrinsic noise in gene expression, and the origins of disease that can only be addressed at the single cell level.
Existing methods for measuring transcript levels in single cells include RT-qPCR, single molecule counting using digital PCR, hydridization probes, and next generation sequencing. Of these, single cell RT-qPCR provides combined advantages of sensitivity, specificity, and dynamic range, but a major disadvantage is the low throughput, high reagent cost, and difficulties in accurately measuring low abundance transcripts. RT-qPCR is a reverse-transcription based DNA amplification method where a transcriptase enzyme makes the complementary-DNA (cDNA) of the RNA and the cDNA is amplified by the polymerase chain reaction (PCR). This method is very useful in quantitative analysis of viral RNA and gene expression in cells.
A linear microfluidic device for sensing, e.g., reactance or capacitance sensing, of one or more substances of interest (i.e., one or more particles or substances in the analyte) is provided. The linear microfluidic device of the present application has a linear microfluidic channel that includes at least one microfluidic sensing cell located along the linear microfluidic channel. The microfluidic sensing cell includes an upper electrode portion that is vertically spaced apart from a lower electrode portion, and each of the upper electrode portion and the lower electrode portion includes at least one electrically isolated probe electrode.
In one aspect of the present application, a linear microfluidic device is provided. In one embodiment, the linear microfluidic device includes a first microfluidic channel extending linearly in a first direction and positioned between a first substrate and a second substrate. The linear microfluidic device further includes at least one microfluidic sensing cell positioned along the first microfluidic channel. The microfluidic sensing cell includes an upper electrode portion including a first group of at least one upper electrically isolated probe electrode and a lower electrode portion including a second group of at least one lower electrically isolated probe electrode. In the present application, at least one upper electrically isolated probe electrode of the first group has a vertical portion that extends entirely through the first substrate and at least one lower electrically isolated probe electrode of the second group has a vertical portion that extends entirely through the second substrate.
In some embodiments, the linear microfluidic device of the present application includes multiple spaced apart microfluidic channels, each of which extends in the same direction. Notably, and in such embodiments, the linear microfluidic device further includes at least one other microfluidic channel located adjacent to and spaced apart from the first microfluidic channel, wherein the at least one other microfluidic channel extends linearly in the first direction and is positioned between the first substrate and the second substrate. In embodiments, at least one other microfluidic channel includes a second microfluidic channel, a third microfluidic channel, a fourth microfluidic channel, . . . , etc. In such embodiments, at least one other microfluidic sensing cell is positioned along at least one other microfluidic channel. At least one other microfluidic sensing cell includes an upper electrode portion including another first group of the at least one upper electrically isolated probe electrode and a lower electrode portion including another second group of at least one lower electrically isolated probe electrode. The at least one upper electrically isolated probe electrode of another first group has a vertical portion that extends entirely through the first substrate and at least one lower electrically isolated probe electrode of the another second group has a vertical portion that extends entirely through the second substrate.
In another aspect of the present application, a method of detecting the presence/absence of biological cells is provided. In one embodiment, the method includes providing a linear microfluidic device including a first microfluidic channel extending linearly in a first direction and positioned between a first substrate and a second substrate, and at least one microfluidic sensing cell positioned along the first microfluidic channel, the at least one microfluidic sensing cell includes an upper electrode portion including a first group of at least one upper electrically isolated probe electrode and a lower electrode portion including a second group of at least one lower electrically isolated probe electrode, wherein the at least one upper electrically isolated probe electrode of the first group has a vertical portion that extends entirely through the first substrate and the at least one lower electrically isolated probe electrode of the second group has a vertical portion that extends entirely through the second substrate. Next, a reactance or a capacitance of a first sample (i.e., liquid, gas, emulsion, or gel) not containing a biological cell is measured across each pair of upper electrically isolated probe electrodes of the first group and lower electrically isolated probe electrode of the second group. A second sample (i.e., same liquid, gas, emulsion, or gel) containing a biological cell is then introduced into the microfluidic channel and the reactance or capacitance of the second sample containing the biological cell is continuously measured across each pair of upper electrically isolated probe electrodes of the first group and lower electrically isolated probe electrode of the second group.
In yet another aspect of the present application, a method of detecting biological cell type is provided. In one embodiment, the method includes providing a linear microfluidic device including a first microfluidic channel extending linearly in a first direction and positioned between a first substrate and a second substrate, and at least one microfluidic sensing cell positioned along the first microfluidic channel, the at least one microfluidic sensing cell includes an upper electrode portion including a first group of at least one upper electrically isolated probe electrode and a lower electrode portion including a second group of at least one lower electrically isolated probe electrode, wherein the at least one upper electrically isolated probe electrode of the first group has a vertical portion that extends entirely through the first substrate and the at least one lower electrically isolated probe electrode of the second group has a vertical portion that extends entirely through the second substrate. Next, a reactance or a capacitance of a first sample (i.e., liquid, gas, emulsion, or gel) not containing a biological cell is measured across each pair of upper electrically isolated probe electrodes of the first group and lower electrically isolated probe electrode of the second group and over a selected frequency range to determine a dielectric constant of the first sample not containing the biological cell over the selected frequency range. A second sample (i.e., same liquid, gas, emulsion, or gel) containing a biological cell is then introduced into the microfluidic channel and the reactance or capacitance of the second sample containing the biological cell is continuously measured across each pair of upper electrically isolated probe electrodes of the first group and lower electrically isolated probe electrode of the second group and over the selected frequency range to determine a dielectric constant of the second sample containing the biological cell.
The present application will now be described in greater detail by referring to the following discussion and drawings that accompany the present application. It is noted that the drawings of the present application are provided for illustrative purposes only and, as such, the drawings are not drawn to scale. It is also noted that like and corresponding elements are referred to by like reference numerals.
In the following description, numerous specific details are set forth, such as particular structures, components, materials, dimensions, processing steps and techniques, in order to provide an understanding of the various embodiments of the present application. However, it will be appreciated by one of ordinary skill in the art that the various embodiments of the present application may be practiced without these specific details. In other instances, well-known structures or processing steps have not been described in detail in order to avoid obscuring the present application.
It will be understood that when an element as a layer, region or substrate is referred to as being “on” or “over” another element, it can be directly on the other element or intervening elements may also be present. In contrast, when an element is referred to as being “directly on” or “directly over” another element, there are no intervening elements present. It will also be understood that when an element is referred to as being “beneath” or “under” another element, it can be directly beneath or under the other element, or intervening elements may be present. In contrast, when an element is referred to as being “directly beneath” or “directly under” another element, there are no intervening elements present.
As stated above, a linear microfluidic device is provided. The linear microfluidic device of the present application has a linear microfluidic channel that includes at least one microfluidic sensing cell (typically a plurality of such cells is present) located along the linear microfluidic channel. The at least one microfluidic sensing cell includes an upper electrode portion that is vertically spaced apart from a lower electrode portion, and each of the upper electrode portion and the lower electrode portion includes at least one electrically isolated probe electrode. The isolated probe electrodes can be sensing probes electrodes alone or sensing probe electrodes in combination with reference probe electrodes.
Such a linear microfluidic device has improved accuracy since there is one path through the at least one microfluidic sensing cell. Also, each sensing cell includes multiple probe electrodes per microfluidic channel. This allows for both ionic (eliminates pervious Helmholtz error) and non-ionic biological cell detection. In some embodiments, the linear microfluidic device can be used for detecting the presence or the absence of biological cells (i.e., cell counting). In other embodiments, the linear microfluidic device can be used for detecting the type of biological cell (e.g., bacteria) that is present.
In embodiments, the linear microfluidic device can have a plurality of linearly connected single microfluidic sensing cells per microfluidic channel, and several parallel channels enabling higher throughput determined by the assay flow rate and the detector sampling speed. The accuracy increase comes from (1) having separate current or voltage stimulus probe electrodes for each microfluidic sensing cell with separate isolated imbedded detection/measurement probe electrodes within the main path of the stimulus probe electrodes, (2) having several microfluidic sensing cells in series, (3) having the option of multiple microfluidic channels, and (4) have the option of a calibration/differential sensing of a second adjacent nearly identical microfluidic channel. The linear microfluidic device of the present application eliminates previous capacitor sensor measurement issues with conducting liquids that are complicated by ionic conductivity and the effects of electrode polarization. The linear microfluidic device when using three or more probe electrodes (with at least two spaced aways from the microfluidic channel walls) overcomes electrode polarization problems by measuring the voltage drop away from the capacitive plates and thereby avoiding the double (Helmholtz) layer. Also, the linear microfluidic device of the present application can be formed by a wafer-to-wafer parallel fabrication manufacturing method that results in substantially lower fabrication cost. Furthermore, the linear microfluidic device can be used for measurements including for example, cell counting and cell sorting with disclosed structure. These and other aspects of the present application will now be described in greater detail.
Reference is first made to
The first microfluidic channel 12 (or any other microfluidic channels that runs parallel to the first microfluidic channel) is a cavity or chamber that exists between the first substrate 10A and the second substrate 10B. In the present application, a gas or liquid (i.e., sample) containing one or more substances (or analytes as defined herein below) of interest can flow through the first microfluidic channel 12 and be sensed by the upper electrically isolated probe electrode 14A and the lower electrically isolated probe electrodes 14B that are associated with the at least one microfluidic sensing cell. In some embodiments, the upper electrically isolated probe electrode 14A and the lower electrically isolated probe electrodes 14B are configured for capacitance sensing.
The first substrate 10A can be composed of a first substrate material, and the second substrate 10B can be composed of a second substrate material. In some embodiments of the present application, the first substrate material that provides the first substrate 10A is compositionally the same as the second substrate material that provides the second substrate 10B. In other embodiments, the first substrate material that provides the first substrate 10A is compositionally different from the second substrate material that provides the second substrate 10B. Exemplary first substrate materials and second substrate materials that can be employed in the present application include, but are not limited to, a semiconductor material, an electrically insulating material, a combination of a semiconductor material and an electrically insulating material.
The term “semiconductor material” is used throughout the present application to denote a material that has semiconducting properties. Examples of semiconductor materials that can be used as the first substrate material and the second substrate mater include, but are not limited to, silicon (Si), a silicon germanium (SiGe) alloy, a silicon germanium carbide (SiGeC) alloy, germanium (Ge), III/V compound semiconductors or II/VI compound semiconductors. Other examples of substrate material may involve glass, ceramic or organic printed circuit boards. In one example, the first substrate material and the second substrate material are both composed entirely of silicon.
Exemplary electrically insulating materials that can be employed as the first substrate material and the second substrate material include, but are not limited to, glass or a polymer. Exemplary polymers that can be employed in the present application include, but are not limited to, poly(ethylene terephthalate) (PET), poly(butylene terephthalate) (PBT), poly(enthylene naphthalate) (PEN), polycarbonate (PC), polyimides (PI), polysulfones (PSO), and poly(p-phenylene ether sulfone) (PES).
In some embodiments, the first substrate 10A and the second substrate 10B are both transparent. Transparent substrates provide for a visual inspection and/or analysis of the one or more substances that pass through the first microfluidic channel 12. In other embodiments, in which the first substrate 10A or the second substrate 10B represents the top substrate, the top substrate is transparent, and the bottom substrate can be transparent or non-transparent. Exemplary transparent substrate materials include glass and/or the polymers mentioned above. Semiconductor materials are exemplary non-transparent substrate materials.
The first microfluidic channel 12 can be laterally surrounded by a spacing element 13. When multiple microfluidic channels are present each microfluidic channel runs parallel to each other and is spaced apart by spacing element 13. Spacing element 13 not only controls the spacing between the first substrate 10A and the second substrate 10B, but determines the height, h, of the first microfluidic channel 12. In some embodiments of the present application, the spacing element 13 is a dielectric material such as, for example, silicon dioxide, silicon nitride, silicon nitride and/or a low dielectric constant (k) material, the term “low k” denotes a dielectric material having a dielectric constant of less than 4.0 as measured under vacuum. In other embodiments of the present application, the spacing element 13 is a gasket, a spacer ball, solder or thin films deposited during fabrication, such as silicon dioxide, silicon nitride or any low K dielectric where the dielectric constant is less than 4.
In the present application, the height, h, of the first microfluidic channel 12 (and any other microfluidic channel) is typically from 1 micron to 1 centimeter, with a height from 1 micron to 100 microns being even more typical. In the present application, the height, h, of the first microfluidic channel 12 (and any other microfluidic channel) can be designed to a desired height dependent on what substance(s) needs to be detected. For example, a small height, h, of the first microfluidic channel 12 can be used to detect small quantities of a substance or substances in a liquid or gas that passes through the first microfluidic channel 12.
In the linear microfluidic device of the present application, the first substrate 10A includes the upper electrode portion of the microfluidic sensing cell and the second substrate includes the lower electrode portion of the microfluidic sensing cell. As stated above, the upper electrode portion includes the first group of at least one upper electrically isolated probe electrode 14A and the lower electrode portion includes the second group of at least one lower electrically isolated probe electrode 14B. In embodiments of the present application, there can be ‘n’ number of upper electrically isolated probe electrodes 14A in the first group and ‘n’ number of lower electrically isolated probe electrodes 14B in the second group, wherein n is an integer starting at one. In one embodiment, n is 1. In another embodiment, n is 2 or 3 or 4, . . . etc.
The upper electrode portion also includes at least one first ground electrode 16A, while the lower electrode portion also includes at least one second ground electrode 16B. In the present application, the first ground electrode 16A has a vertical portion that extends entirely through the first substrate 10A and the second ground electrode 16B has a vertical portion that extends entirely through the second substrate 10B. Each vertical portion is present in a through-via that is present in the first substrate 10A or in the second substrate 10B. The first ground electrode 16A and the second ground electrode 16B are electrically isolated.
In accordance with the present application, the upper electrically isolated probe electrode 14A of the first group is mated, i.e., paired, with the lower electrically isolated probe electrode 14B of the second group. Throughout the present application, the term “mated” denotes that the probe electrodes are paired and have a cooperative working relationship with each other.
In some embodiments of the present application, the upper electrically isolated probe electrode 14A of the first group is vertically aligned with the lower electrically isolated probe electrode 14B of the second group. In other embodiments, the upper electrically isolated probe electrode 14A of the first group is vertically offset, yet overlapping, the lower electrically isolated probe electrode 14B of the second group.
In some embodiments, the upper electrically isolated probe electrode 14A of the first group and the lower electrically isolated probe electrode 14B of the second are non-coaxed. In other embodiments, the upper electrically isolated probe electrode 14A of the first group is coaxed with the first ground electrode 16A and the lower electrically isolated probe electrode 14B of the second group is coaxed with the second ground electrode 16B. The coaxial embodiment adds additional electromigration shielding to the electrodes.
In embodiments, the upper electrically isolated probe electrode 14A and the lower electrically isolated probe electrode 14B as well as the first and second ground electrodes 16A, 16B have contact pads (not shown). Each corresponding contact pad and electrode combination is typically of unitary construction and is typically composed of same electrically conductive material. The contact pads can be used to electrically connect the electrodes of the first group of and electrode of the second group to external circuitry and/or external devices. In some embodiments, signal wires can be formed and use to electrically connect via the corresponding contact pad each of the electrodes of the first and second groups to external circuitry.
In some embodiments of the present application, the electrically conductive material that provides the upper electrically isolated probe electrode 14A, the lower electrically isolated probe electrode 14B, the first ground electrode 16A, the second ground electrode 16B and, if present, the contact pads, is composed of a non-transparent electrically conductive material such as, for example, copper (Cu), platinum (Pt), gold (Au), silver (Ag), nickel (Ni), tungsten (W), aluminum (Al) or alloys thereof. In other embodiments of the present application, the electrically conductive material that provides the upper electrically isolated probe electrode 14A, the lower electrically isolated probe electrode 14B, the first ground electrode 16A, the second ground electrode 16B and, if present, the contact pads, is composed of a transparent electrically conductive material such as, for example, indium tin oxide (ITO), zinc oxide, cadmium oxide, or titanium oxide.
In some embodiments of the present application, ground electrodes are composed of a compositionally same electrically conductive material as each of the probe electrodes. In other embodiments of the present application the ground electrodes are composed of a compositionally different electrically conductive material than each of the probe electrodes.
In some embodiments of the present application and as illustrated in
In the present application, the upper electrically isolated probe electrode 14A and the lower electrically isolated probe electrode 14B can be designed to have probe head that has a greater surface area than the other probe electrodes. This flexibility allows the tradeoff of a better signal-to-noise for a give microfluidic channel 12 volume since capacitive sensing via the probes 14A and 14B is directly proportional to the probe area.
In the present application, the upper electrically isolated probe electrode 14A is encased in an upper electrically insulating layer 22A, and the second electrically isolated probe electrode 14B encased in a lower electrically insulating layer 22A; the sensing surface and the contact pad of each of the upper electrically isolated probe electrode 14A and the lower electrically isolated probe electrode 14B does not include any electrically insulator material thereon. The upper electrically insulating layer 22A and the lower electrically insulating layer 22B are composed of one or more dielectric materials such as, for example, silicon dioxide, silicon nitride, and/or a low dielectric constant (low k) material such as organosilicate glass. The dielectric material(s) that provides the upper electrically conductive insulating layer 22A can be compositionally the same as, or different from, the dielectric material that provides the lower electrically insulating layer 22B.
In some embodiments (not shown in
In some embodiments (not shown in
The linear microfluidic device of the present application can be formed utilizing processing techniques that are well known to those skilled in semiconductor manufacturing. In the present application, the first substrate 10A can be processed to include the first group of the at least one upper electrically isolated probe electrode 14A and the first ground electrode 16A, and the second substrate 10B can be processed to include the second group of the at least one lower electrically isolated probe electrode 14B and the second ground electrode 16A. In embodiments, the first substrate 10 can also be processed to include the thermistor and the second substrate 10B can also be processed to include the resistive heating element. The processing of the first and second substrates 10A, 10B can include forming at least two through-vias into the first and second semiconductor materials, and various metallization steps that include insulator material deposition, electrically conductive material deposition (e.g., seed layer deposition and plating), and lithography patterning. The processing can provide non-coaxial or coaxial probe electrodes. The lithography patterning includes one or more etching processes.
Spacing element 13 can then be formed on of, or both of, the processed substrates, e.g., first substrate 10A, and a bonding processing can be used to bond the two processed substrates together.
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
In the present application there are several arrangements possible for the fluidic inlet ports 24 and the fluidic outlet ports 26. In one example, each microfluidic channel is singular and is isolated from each other providing “n” isolated channels as is shown in
The one or more substances that can be sensed using the linear microfluidic device of the present application can be referred to as an analyte. As used herein, the term “analyte” or “analytes” is any biomolecule that can be recognized. In some embodiments, an analyte is a polypeptide. As used herein, a “polypeptide” is a single polymer chain of amino acids bonded together by peptide bonds between the carboxyl and amino groups of adjacent amino acid residues. The term “protein” includes polypeptide. The term “protein” may also be used to describe a polypeptide, having multiple domains, such as beta sheets, linkers and alpha-helices. As such, the term “protein” is also meant to include polypeptides having quaternary structures, ternary structures and other complex macromolecules composed of at least one polypeptide. If the protein is comprised of more than one polypeptide that physically associate with one another, then the term “protein” as used herein refers to the multiple polypeptides that are physically coupled and function together as the discrete unit.
In embodiments of the present application, an analyte is any polypeptide that includes an epitope or amino acid sequence of interest. Such polypeptide can be isolated from cells, synthetically produced, or recombinantly produced using means known by those of ordinary skill in the art. In some embodiments, an analyte is any polypeptide that includes an epitope or amino acid sequence of interest. In certain embodiments, polypeptide (protein) analytes can be isolated from cells or viruses, synthetically produced, or recombinantly produced. In one embodiment, an analyte is a protein or a fragment thereof that has been produced by a cell or virus. In certain embodiments, the analyte is a protein that is present on the outermost surface of the cellular membrane or viral capsid. In one embodiment, the protein present on the outermost surface of the cellular membrane or viral capsid has an antigen or epitope that is accessible to a label (e.g., antibody, dye). In yet other embodiments, an analyte is a protein or a fragment thereof that has been secreted by a cell.
In certain exemplary embodiments, an analyte is hemagglutinin present on a surface of an influenza virus, a derivative, analog or homolog thereof. In other exemplary embodiments, an analyte is a cell surface protein known by those of ordinary skill in the art. In other embodiments, the analyte is a nucleic acid. The nucleic acid analyte can be a deoxy-ribonucleic acid (DNA), e.g., genomic DNA or isolating coding DNA. In other embodiments, the nucleic acid analyte can be a ribonucleic acid (RNA), such as messenger RNA, ribosomal RNA molecule. The nucleic acid analyte can be single stranded or double stranded.
In certain embodiments, the analyte of interest can be affixed (bound) to a detectable label. The term “label” or “detectable label” as used herein means a molecule, such as a dye, nanoparticle, oligonucleotide, or an antibody that is capable of binding to an analyte of interest when contacted by the analyte. A label may be directly detectable (e.g., fluorescent moieties, electrochemical labels, electrochemical luminescence labels, metal chelates, colloidal metal particles, quantum dots), as well as a molecule or molecules that may be indirectly detected by production of a detectable reaction product (e.g., enzymes such as horseradish peroxidase, alkaline phosphatase and the like), a molecule or molecules that can be detected by recognition of a molecule that specifically binds to the detection antibody such as, a labeled antibody that binds to the detection antibody, biotin, digoxigenin, maltose, oligohistidine, 2,4-dintrobenzene, phenylarsenate, a nucleic acid (e.g., ssDNA, dsDNA) or the like).
Labels for use in the present application can be provided on the surface of the probe electrodes that extend into the microfluidic channel or a label can be provided to a sample prior to introduction to a micro-capacitive sensor array of the present application. In certain embodiments, the label is affixed to the probe electrodes that extend into the microfluidic channel such that a binding portion (e.g., antigen-binding portion of an antibody) of the label is positioned such that the binding portion can be contacted by the portion of the analyte to which it binds (e.g., antigen) when presented thereto. In other instances, the probe electrodes that extend into the microfluidic channel can be coated with a label, which when contacted with an analyte removes the label from the structure.
A “sample” or a portion thereof is provided to linear microfluidic device of the present application; the sample can be a liquid, gas, emulsion, or gel. The sample contains at least one analyte (i.e. substance) of interest, such as a protein or nucleic acid. Regardless of the number of analytes or analytes of interest, the sample can be readily applied to a micro-capacitive sensor array of the present application. In certain embodiments, a sample may be obtained from a subject, or may be obtained from other materials. The term “subject” as used herein refers to a human or non-human organism. Further, while a subject is preferably a living organism, the subject can also be in post-mortem analysis as well. Subjects that are humans can be “patients,” which as used herein refers to living humans that are receiving or may receive medical care for a disease or condition.
In some instances, the sample is created for the purpose of determining the presence of certain analytes therein. For example, a sample may be obtained from cell culture, a fluid or tissue known to include, or not include the analyte(s) of interest. In other instances, the sample is created by adding synthetic or recombinantly produced peptides to a solution that is easily stored and dispensed. In specific embodiments, samples for use in the present methods are body fluid samples obtained from a subject, such as a patient. In some embodiments, samples of the present disclosure include blood, tears serum, plasma, cerebrospinal fluid, urine, saliva, sputum, and pleural effusions. One of skill in the art would realize that certain samples would be more readily analyzed following processing, e.g., fractionation or purification. For example, fractionation of whole blood obtained from a subject into serum and/or plasma components. Hence, a sample can be used as is, or can be treated to result in a final sample for detection of analytes. For example, a sample can be liquefied, concentrated, dried, diluted, lyophilized, extracted, fractionated, subjected to chromatography, purified, acidified, reduced, degraded, subjected to enzymatic treatment, or otherwise treated in ways known to those having ordinary skill in the art in order to release an analyte of interest. If desired, a sample can be a combination (pool) of samples, e.g., from an individual or from a manufacturing process.
A sample can be in a variety of physical states, such as liquid, gas, emulsion, or gel. Samples can be treated with customary care to preserve analyte integrity. Treatment can include the use of appropriate buffers and/or inhibitors, such as inhibitors of certain biological enzymes. One having ordinary skill in the art will be able to determine the appropriate conditions given the analytes of interest and the nature of the sample.
For example, the sample can be liquid and the amount of a liquid sample provided to a microfluidic sensing cell of the present application can be from 1-100 mL, 1-50 mL, 1-40 mL, 1-30 mL, 1-20 mL, 1-10 mL, 1-5 mL, 1-4 mL, 1-3 mL, 1-2 mL or less than 2 mL of sample. In some embodiments, the amount of liquid sample is from 1-100 μL, 1-50 μL, 1-40 μL, 1-30 μL, 1-20 μL, 1-10 μL, 1-5 μL or less of sample.
In another aspect of the present application, a method for detecting the presence or absence of a biological cell is provided in which the linear microfluidic device is employed. The method considers the reactance (or capacitance) measurement of a pair of upper and lower probe electrodes arranged in 1D sequentially where the biological cells would pass through. The biological cells can be bacteria or virus. The biological cells can be plant or animal. A single pass ensures no misses or double counting. The reactance (or capacitance) is expected to change when a single biological cell or a cluster of biological cells pass through them.
In one embodiment, the method can include monitoring the reactance (or capacitance) measured across each pair of upper and lower probe electrodes in the absence of any biological cell or cluster of biological cells over a period of time. This provides a baseline for empty cell reactance (averaged over a time window, Zbase(t); or Cbsae(t). A first sample (fluid, gas, etc.) not containing the biological cell is then introduced into the microfluidic channel and that first sample is allowed to pass through the pair of upper and lower probe electrodes. During this stage, the reactance/capacitance is continuously measured. This provides a baseline for the first sample without the biological cell. A second sample (fluid, gas, etc.) containing the biological cell is then introduced into the microfluidic channel and that second sample is allowed to pass through the pair of upper and lower probe electrodes. Note that the fluid, gas, etc. that provides the second sample is the same as that which provides the first sample. During this stage, the reactance/capacitance is continuously measured. As the biological cell occupies a single pair of upper and lower probe electrodes, it will change the measured reactance or capacitance. This is expected to be a pulse-like change being caused in the dielectric constant as well as the conductance (i.e., impedance) of the medium occupied by a single cell band and its surrounding. This method is shown in
Notably,
Referring now to
When the answer to yes is obtained in step 108, the method continues at step 110 by continuing the measurement with the same sampling frequency. After performing step 110, a determination can be made whether or not there is a statistically significant number of biological cells detected. See, step 112. If the answer is no, step 110 can be repeated until there is a statistically significant number of biological cells detected. When a statistically significant number of biological cells are detected, the method continues to step 114 in which includes running offline data analytics for counting the cells detected or for training DL models for counting is performed. The models will be trained with different classes of signals that correspond to either the absence or presence of biological cells between one electrode pair during measurement time. In the case of biological cells detected in the signal, it would also further identify how many of them were detected during measurement as outlined above in reference to (b) of
In another embodiment, the linear microfluidic device of the present application can be used in a method for detecting the type of bacterial cells within a fluid/gas. Notably, the frequency response of the dielectric constant of bacterial suspensions show plateaus in different regions of the frequency (between 0.1 to 100 MHZ) that smoothly transition from one another. This behavior suggests that the derivative of them (See,
The method for detecting the type of bacterial cells within a fluid/gas can include a step of first introducing a fluid/gas containing no bacteria/virus/biological cell into the microfluidic channel of the linear microfluidic device of the present application and thereafter taking a background measurement, e.g., capacitance or reactance. The background measurement is taken over a wide range of frequencies (for example, between 0.1 to 100 MHZ) to extract the dielectric constant of the background medium. The method continues by introducing a fluid/gas containing a bacteria/virus/biological cell into the microfluidic channel of the linear microfluidic device of the present application and thereafter taking measurements of this medium over the same range of frequencies to obtain a dielectric constant over this frequency range. The derivative of the dielectric constant over this frequency range is then obtained and the different peaks (such as was shown in
Referring now
When the answer to yes is obtained in step 208, the method continues at step 210 by continuing the measurement with the same sampling frequency. After performing step 210, a determination can be made whether or not there is a statistically significant number of biological cells detected. See, step 212. If the answer is no, step 210 can be repeated until there is a statistically significant number of biological cells detected. When a statistically significant number of biological cells are detected, the method continues to step 214 in which includes running offline data analytics for counting the cells detected or for training DL models for counting is performed. After performing step 214, a determination can made (see, step 216) whether or not the data analytics detected enough cell detection events. If the data analytics did not detect enough cell detection events, the method reverts to step 210 and steps 210, 212, and 214 can be repeated until the data analytics detect enough cell detection events. When the data analytics detect enough cell detection events, the method continues to step 218 in which a determination can be made whether or not the training/refining NN models for online cell detection and counting are completed. If the determination is made in step 216 that the training/refining NN models for online cell detection and counting are incomplete, the method reverts to step 210 and steps 210, 212, and 214 can be repeated until there is a determination in step 218 that the training/refining NN models for online cell detection and counting are completed. When the training/refining NN models for online cell detection and counting are completed, the method ends with cell detection and recognition, see step 220.
While the present application has been particularly shown and described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that the foregoing and other changes in forms and details may be made without departing from the spirit and scope of the present application. It is therefore intended that the present application not be limited to the exact forms and details described and illustrated, but fall within the scope of the appended claims.